[HTML][HTML] Systematically optimized topical delivery system for Loperamide hydrochloride: Formulation design, in vitro and in vivo biopharmaceutical evaluation
J Shu, J Zhao, F Guo - asian journal of pharmaceutical sciences, 2018 - Elsevier
This study aimed to develop a suitable topical delivery system containing diethylene glycol
monoethyl ether (DGME) for Loperamide hydrochloride (Lop). Two factors, three levels …
monoethyl ether (DGME) for Loperamide hydrochloride (Lop). Two factors, three levels …
Development of the loratadine gel for enhanced transdermal delivery
JH Song, SC Shin - Drug development and industrial pharmacy, 2009 - Taylor & Francis
Background: The oral administration of loratadine, an antihistamine, can have a variety of
adverse side effects, such as headache, fatigue, and nausea, because of the transient high …
adverse side effects, such as headache, fatigue, and nausea, because of the transient high …
Effect of pH, vehicles and chemical enhancers on the skin permeation of loratadine
Z Li, T Hao, P Ding, L Mei, D Gao, K Liu… - … American Journal of …, 2011 - sedici.unlp.edu.ar
The objective of this work was to investigate feasibility of transdermal delivery of loratadine.
Effect of pH, vehicles and chemical enhancers on the skin permeation of loratadine was …
Effect of pH, vehicles and chemical enhancers on the skin permeation of loratadine was …
Ethosomal hydrogel of raloxifene HCl: Statistical optimization & ex vivo permeability evaluation across microporated Pig ear skin
HP Thakkar, H Savsani, P Kumar - Current Drug Delivery, 2016 - ingentaconnect.com
Background: The oral bioavailability of Raloxifene hydrochloride, an FDA approved
selective estrogen receptor modulator, is severely limited due to its poor aqueous solubility …
selective estrogen receptor modulator, is severely limited due to its poor aqueous solubility …
Formulation and development of proniosomal gel for transdermal delivery of ketorolac tromethamine
N Farooqui - Asian Journal of Pharmaceutics (AJP), 2016 - asiapharmaceutics.info
Aim: The aim of this study was to formulate and perform characterization, permeability
enhancement studies, in-vitro, in-vivo evaluation of prepared formulation and stability …
enhancement studies, in-vitro, in-vivo evaluation of prepared formulation and stability …
Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel
N Akhtar, K Pathak - AAPS pharmscitech, 2012 - Springer
The present research work was aimed to formulate clotrimazole encapsulated Cavamax W7
composite ethosomes by injection method for improved delivery across epidermis. 3 2 …
composite ethosomes by injection method for improved delivery across epidermis. 3 2 …
[PDF][PDF] Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model …
KS Iwaszkiewicz, S Hua - Pain Physician, 2014 - painphysicianjournal.com
Background: Peripheral opioid receptor targeting has been well established as a novel
target in clinical pain management for acute and chronic peripheral inflammatory pain. The …
target in clinical pain management for acute and chronic peripheral inflammatory pain. The …
Transdermal drug delivery of labetalol hydrochloride: Feasibility and effect of penetration enhancers
Objectives: The objective of this study is to investigate the feasibility of transdermal drug
delivery of Labetalol Hydrochloride (LHCl) and to study the effect of different penetration …
delivery of Labetalol Hydrochloride (LHCl) and to study the effect of different penetration …
Emulgel based topical delivery system for loratadine
Sažetak The present study was taken up with the objective of formulating emulgels to
facilitate topical delivery of loratadine in the treatment of localized skin allergy. It was …
facilitate topical delivery of loratadine in the treatment of localized skin allergy. It was …
[HTML][HTML] Enhanced controlled transdermal delivery of mexazolam using ethylene-vinyl acetate
CW Cho, SC Shin - Iranian Journal of Pharmaceutical Research …, 2012 - ncbi.nlm.nih.gov
Repeated oral administration of mexazolam, an anti-anxiety agent, may cause adverse
effects such as gastric disturbance, drowsiness, and ataxia due to transiently high blood …
effects such as gastric disturbance, drowsiness, and ataxia due to transiently high blood …